Konko AI
An interoperable AI platform helps healthcare providers reduce administrative burden so doctors can spend more time on patient care.
Overview
Konko AI builds an interoperable AI platform for healthcare, positioned to help doctors reclaim time for direct patient care. Its target market is clinicians and healthcare organizations looking to reduce workflow friction and improve care-team productivity. The company’s stated differentiator is interoperability, suggesting a platform designed to work across existing healthcare environments rather than as a standalone point tool. Konko AI has raised $6 million in an undisclosed round announced in September 2026 to scale the platform.
Funding History
Konko AI Secures $6 Million to Scale Interoperable AI Platform that Gives Doctors More Time for Patient Care
Frequently Asked Questions
- How much funding does AI Funding track for Konko AI?
- AI Funding tracks $6M for Konko AI across 1 funding round in this database.
- What does Konko AI do?
- Konko AI builds an interoperable AI platform for healthcare, positioned to help doctors reclaim time for direct patient care. Its target market is clinicians and healthcare organizations looking to reduce workflow friction and improve care-team productivity. The company’s stated differentiator is interoperability, suggesting a platform designed to work across existing healthcare environments rather than as a standalone point tool. Konko AI has raised $6 million in an undisclosed round announced in September 2026 to scale the platform.
- Where is Konko AI headquartered?
- Konko AI is headquartered in San Francisco, CA.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.